´Ü¹éÁú Ä¡·áÁ¦ ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ±â¼úº°, Åõ¿© °æ·Îº°, ÃÖÁ¾ »ç¿ëÀÚº°
Protein Therapeutics Market, By Product Type, By Application, By Technology, By Route of Administration,By End User: Hospitals, Clinics, Research Laboratories, and Pharmaceutical and Biotechnology Companies
»óǰÄÚµå : 1812436
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,376,000
Unprintable PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,919,000
PDF & Excel (Multi User License - Up to 7 Users) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ÃÖ´ë 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,171,000
PDF & Excel (Corporate User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù. Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

´Ü¹éÁú Ä¡·áÁ¦ ½ÃÀåÀº 2025³â¿¡ 3,458¾ï 2,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2032³â±îÁö 5,589¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â±îÁö ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 7.1%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ ¿¬µµ 2024³â ½ÃÀå ¸ÅÃâ(2025³â) 3,458¾ï 2,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2020-2024³â
¿¹Ãø ±â°£(2025-2032³â)ÀÇ CAGR : 7.10% ±Ý¾× ¿¹Ãø(2032³â) 5,589¾ï 5,000¸¸ ´Þ·¯

¼¼°èÀÇ ´Ü¹éÁú Ä¡·á ½ÃÀåÀº Á¦¾à »ê¾÷ ³»¿¡¼­ ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ºÎ¹®À¸·Î, ´Ù¾çÇÑ Áúº´ ¹× ÀÇÇÐÀû »óŸ¦ Ä¡·áÇϱâ À§ÇØ ¼³°èµÈ Ä¡·á¿ë ´Ü¹éÁúÀÇ °³¹ß ¹× »ó¿ëÈ­°¡ Ư¡ÀÔ´Ï´Ù. ´Ü¹éÁú Ä¡·á ½ÃÀåÀº ´ÜÀÏŬ·Ð Ç×ü, ÀçÁ¶ÇÕ ´Ü¹éÁú, ¹é½Å, Ç÷¾× ¿äÀÎ, È¿¼Ò Ä¡·áÁ¦ µî ÀÎüÀÇ ÀÚ¿¬ÀûÀÎ ´Ü¹éÁú ¸ÞÄ¿´ÏÁòÀ» Ä¡·áÀû °³ÀÔ¿¡ Ȱ¿ëÇÏ´Â ´Ù¾çÇÑ »ý¹°ÇÐÀû Á¦Á¦¸¦ Æ÷ÇԵ˴ϴÙ.

ÀÌ ½ÃÀåÀº »ý¸í°øÇÐÀÇ ¹ßÀü, ´Ü¹éÁú ±¸Á¶-±â´É °ü°è¿¡ ´ëÇÑ ÀÌÇØµµ Çâ»ó, ±×¸®°í º¹ÀâÇÑ »ý¹°ÇÐÀû ºÐÀÚÀÇ ´ë±Ô¸ð »ý»êÀ» °¡´ÉÇÏ°Ô ÇÏ´Â Á¤±³ÇÑ Á¦Á¶ °øÁ¤¿¡ ÀÇÇØ ÃËÁøµÈ Àü·Ê ¾ø´Â ¼ºÀåÀ» °æÇèÇØ ¿Ô½À´Ï´Ù. Ä¡·áÀû ¿ëµµ ºÐ¾ß´Â Á¾¾çÇÐ, ÀÚ°¡¸é¿ª Áúȯ, ´ë»ç¼º Áúȯ, °¨¿°º´, Èñ±Í À¯Àü Áúȯ µî ´Ù¾çÇÑ Áúȯ ¿µ¿ª¿¡ °ÉÃÄ ÀÖ¾î, ´Ü¹éÁú Ä¡·á ½ÃÀåÀº ÃÖ±Ù ÀÇÇп¡¼­ °¡Àå ´ÙÀç´Ù´ÉÇϰí À¯¸ÁÇÑ ºÎ¹® Áß Çϳª·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

¸¸¼º ÁúȯÀÇ Áõ°¡, Àü ¼¼°è Àα¸ °í·ÉÈ­, ¸ÂÃãÇü ÀǾàǰ Á¢±Ù¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ´Ü¹éÁú Ä¡·á ½ÃÀåÀº ÀǾàǰ, ¹ÙÀÌ¿ÀÅ×Å© ±â¾÷, ¿¬±¸ ±â°üÀ¸·ÎºÎÅÍ »ó´çÇÑ ´ë±Ô¸ð ÅõÀÚ¸¦ À¯Ä¡ÇÏ¸ç ¹Ì·¡ ÀÇ·á ¼Ö·ç¼Ç°ú ÀÇÇÐ Çõ½Å Àü·«ÀÇ ÇÙ½É ÄÄÆ÷³ÍÆ®·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼¼°èÀÇ ´Ü¹éÁú Ä¡·á ½ÃÀåÀº ÁÖ·Î ´ÙÀ½°ú °°Àº ÁÖ¿ä ¿äÀε鿡 ÀÇÇØ ÃËÁøµÇ¸ç, À̵éÀÌ Á¾ÇÕÀûÀ¸·Î °­·ÂÇÑ ¼ºÀå ±Ëµµ¸¦ À̲ø°í ÀÖ½À´Ï´Ù. ¾Ï, ´ç´¢º´, ÀÚ°¡¸é¿ª Áúȯ, ½ÉÇ÷°ü Áúȯ µî ¸¸¼º ÁúȯÀÇ Áõ°¡ÇÏ´Â À¯º´·üÀº ±âÁ¸ ¼ÒºÐÀÚ ¾à¹° ´ëºñ ¿ì¼öÇÑ È¿´É°ú °¨¼ÒµÈ ºÎÀÛ¿ëÀ» Á¦°øÇÏ´Â Çõ½ÅÀûÀÎ ´Ü¹éÁú ±â¹Ý Ä¡·áÁ¦¿¡ ´ëÇÑ »ó´çÇÑ ¼ö¿ä¸¦ âÃâÇÕ´Ï´Ù. ÀçÁ¶ÇÕ DNA ±â¼ú, ´Ü¹éÁú °øÇÐ, »ý¹°°øÁ¤ ´É·ÂÀÇ ±â¼úÀû ¹ßÀüÀº º¹ÀâÇÑ ´Ü¹éÁú Ä¡·áÁ¦ÀÇ °³¹ß ¹× Á¦Á¶ È¿À²¼ºÀ» Å©°Ô Çâ»ó½ÃÄ×À¸¸ç, ±ÔÁ¦ ü°è´Â ȹ±âÀûÀÎ Ä¡·á¹ý¿¡ ´ëÇÑ ½Å¼ÓÇÑ ½ÂÀÎ ÀýÂ÷¸¦ µÞ¹ÞħÇϵµ·Ï ÁøÈ­Çß½À´Ï´Ù.

¼¼°èÀûÀ¸·Î °í·É Àα¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ³ëÈ­ °ü·Ã Áúȯ¿¡ ´ëÇÑ È¿°úÀûÀÎ Ä¡·á¹ý Çʿ伺ÀÌ Áõ´ëµÇ°í ÀÖÀ¸¸ç, ¸ÂÃãÇü ÀÇÇÐÀÇ ÀÌÇØ°¡ È®´ëµÊ¿¡ µû¶ó Ç¥Àû ´Ü¹éÁú Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä°¡ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÃÀå¿¡´Â ±Øµµ·Î ³ôÀº ¿¬±¸°³¹ß ºñ¿ë, Àü¹® ½Ã¼³°ú Àü¹®¼ºÀ» ¿ä±¸ÇÏ´Â º¹ÀâÇÑ Á¦Á¶ °øÁ¤, °³¹ß ±â°£À» ¿¬Àå½ÃŰ´Â ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, ´Ü¹éÁú ¾ÈÁ¤¼º, ÀúÀå ¹× Àü´Þ°ú °ü·ÃµÈ »ó´çÇÑ °úÁ¦ µî ÁÖ¸ñÇÒ ¸¸ÇÑ Á¦¾à ¿äÀεéÀÌ Á¸ÀçÇÕ´Ï´Ù.

ºí·Ï¹ö½ºÅÍ ´Ü¹éÁú ÀǾàǰÀÇ Æ¯Çã ¸¸·á´Â ¹ÙÀÌ¿À½Ã¹Ð·¯ °æÀïÀ¸·Î À̾îÁ® ¿ø°³¹ß»çÀÇ ¼öÀÍ È帧¿¡ ÀáÀçÀû ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµÀü¿¡µµ ºÒ±¸Çϰí, ½ÅÈï ½ÃÀå È®´ë, Ç×ü-¾à¹° º¹ÇÕü ¹× ÀÌÁ߯¯À̼º Ç×ü¿Í °°Àº ÇâÈÄ ´Ü¹éÁú °øÇÐ ±â¼ú °³¹ß, ¹ÌÃæÁ· ÀÇ·á ¼ö¿ä°¡ ³ôÀº Èñ±ÍÁúȯ Ä¡·á ºÐ¾ß¿¡¼­ÀÇ ¿ëµµ È®´ë, Ä¡·á È¿°ú ¹× ȯÀÚ °ü¸®¸¦ Çâ»ó½Ã۱â À§ÇØ ´Ü¹éÁú Ä¡·áÁ¦¸¦ ´Ù¸¥ Ä¡·á ¸ð´Þ¸®Æ¼¿Í ÅëÇÕÇÏ´Â º´¿ë ¿ä¹ýÀÇ Áõ°¡Çϴ äÅÃÀ» ÅëÇØ »ó´çÇÑ ±âȸ°¡ Á¸ÀçÇÕ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ´Ü¹éÁú Ä¡·áÁ¦ ½ÃÀå, Á¦Ç° À¯Çüº°(2020-2032³â)

Á¦5Àå ¼¼°èÀÇ ´Ü¹éÁú Ä¡·áÁ¦ ½ÃÀå, ¿ëµµº°(2020-2032³â)

Á¦6Àå ¼¼°èÀÇ ´Ü¹éÁú Ä¡·áÁ¦ ½ÃÀå, ±â¼úº°(2020-2032³â)

Á¦7Àå ¼¼°èÀÇ ´Ü¹éÁú Ä¡·áÁ¦ ½ÃÀå, Åõ¿© °æ·Îº°(2020-2032³â)

Á¦8Àå ¼¼°èÀÇ ´Ü¹éÁú Ä¡·áÁ¦ ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°(2020-2032³â)

Á¦9Àå ¼¼°èÀÇ ´Ü¹éÁú Ä¡·áÁ¦ ½ÃÀå, Áö¿ªº°(2020-2032³â)

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå ¾Ö³Î¸®½ºÆ®ÀÇ Á¦¾È

Á¦12Àå Âü°í¹®Çå°ú Á¶»ç¹æ¹ý

HBR
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Protein Therapeutics Market is estimated to be valued at USD 345.82 Bn in 2025 and is expected to reach USD 558.95 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 345.82 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.10% 2032 Value Projection: USD 558.95 Bn

The global protein therapeutics market represents a rapidly evolving segment within the pharmaceutical industry, characterized by the development and commercialization of therapeutic proteins designed to treat various diseases and medical conditions. Protein therapeutics encompass a diverse range of biological molecules including monoclonal antibodies, recombinant proteins, vaccines, blood factors, and enzyme therapies that leverage the body's natural protein mechanisms for therapeutic intervention.

This market has experienced unprecedented growth driven by advancements in biotechnology, improved understanding of protein structure-function relationships, and sophisticated manufacturing processes that enable large-scale production of complex biological molecules. The therapeutic applications span across multiple disease areas including oncology, autoimmune disorders, metabolic diseases, infectious diseases, and rare genetic conditions, making protein therapeutics one of the most versatile and promising segments in modern medicine.

With increasing prevalence of chronic diseases, aging populations worldwide, and growing demand for personalized medicine approaches, the protein therapeutics market continues to attract significant investment from pharmaceutical companies, biotechnology firms, and research institutions, positioning it as a critical component of future healthcare solutions and medical innovation strategies.

Market Dynamics

The global protein therapeutics market is primarily driven by several key factors that collectively propel its robust growth trajectory. The increasing prevalence of chronic diseases such as cancer, diabetes, autoimmune disorders, and cardiovascular conditions creates substantial demand for innovative protein-based therapeutic solutions that offer superior efficacy and reduced side effects compared to traditional small-molecule drugs. Technological advancements in recombinant DNA technology, protein engineering, and bioprocessing capabilities have significantly enhanced the development and manufacturing efficiency of complex protein therapeutics, while regulatory frameworks have evolved to support faster approval pathways for breakthrough therapies.

The growing aging population worldwide amplifies the need for effective treatments for age-related diseases, and the expanding understanding of personalized medicine drives demand for targeted protein therapies. However, the market faces notable restraints including extremely high research and development costs, complex manufacturing processes requiring specialized facilities and expertise, stringent regulatory requirements that extend development timelines, and significant challenges related to protein stability, storage, and delivery.

Patent expiration of blockbuster protein drugs leads to biosimilar competition, potentially impacting revenue streams for original manufacturers. Despite these challenges, substantial opportunities exist through emerging markets expansion, development of next-generation protein engineering technologies such as antibody-drug conjugates and bispecific antibodies, increasing applications in rare disease treatments where unmet medical needs remain high, and growing adoption of combination therapies that integrate protein therapeutics with other treatment modalities to enhance therapeutic outcomes and patient care.

Key Features of the Study

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Protein Therapeutics Market, By Product Type, 2020-2032, (USD Bn)

5. Global Protein Therapeutics Market, By Application, 2020-2032, (USD Bn)

6. Global Protein Therapeutics Market, By Technology, 2020-2032, (USD Bn)

7. Global Protein Therapeutics Market, By Route of Administration, 2020-2032, (USD Bn)

8. Global Protein Therapeutics Market, By End User, 2020-2032, (USD Bn)

9. Global Protein Therapeutics Market, By Region, 2020 - 2032, Value (USD Bn)

10. Competitive landscape

11. Analyst Recommendations

12. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â